Profile data is unavailable for this security.
About the company
SHANDONG BUCHANG PHARMACEUTICALS CO., LTD. is a China-based company principally engaged in the research, development, manufacture and distribution of Chinese patent medicines. The Company’s main products are compound traditional Chinese medicines, including cerecarton capsules,wenxin granules, as well as danhong injections, among others. Its products are mainly applied to the fields of cardio-cerebrovascular diseases and gynecological diseases. The Company distributes its products within domestic market and to overseas markets, with North China, East China and Central China as its major markets.
- Revenue in CNY (TTM)11.78bn
- Net income in CNY-293.31m
- Incorporated2001
- Employees8.31k
- LocationShandong Buchang Pharmaceuticals Co LtdNo. 369Zhonghua West Road, Mudan DistrictHEZE 274000ChinaCHN
- Phone+86 5 305299167
- Fax+86 5 305299286
- Websitehttp://www.buchang.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Zhejiang Medicine Co., Ltd. | 9.03bn | 977.95m | 15.35bn | 6.23k | 15.60 | 1.48 | -- | 1.70 | 1.02 | 1.02 | 9.54 | 10.75 | 0.694 | 2.94 | 6.01 | 1,450,206.00 | 6.57 | 4.32 | 8.36 | 5.68 | 36.63 | 36.57 | 9.46 | 6.28 | 1.78 | 26.62 | 0.0684 | 58.72 | -3.96 | 2.59 | -20.37 | 3.34 | 12.65 | 0.00 |
| Shanghai Shyndec Pharmaceutical Co Ltd | 11.50bn | 1.08bn | 16.23bn | 11.61k | 14.99 | 1.24 | -- | 1.41 | 0.8071 | 0.8071 | 8.58 | 9.75 | 0.588 | 3.11 | 7.16 | 990,814.20 | 6.99 | 4.85 | 10.16 | 8.17 | 37.73 | 43.00 | 11.88 | 7.03 | 2.03 | -- | 0.1012 | 17.52 | -6.86 | 1.29 | 10.21 | -0.3897 | -2.21 | 0.00 |
| Tonghua Dongbao Pharmaceutical Co Ltd | 2.43bn | 341.31m | 16.53bn | 3.20k | 53.88 | 2.57 | -- | 6.80 | 0.1548 | 0.1548 | 1.25 | 3.24 | 0.3394 | 0.7426 | 3.70 | 760,839.10 | 4.76 | 18.68 | 5.04 | 19.68 | 77.31 | 78.73 | 14.03 | 39.20 | 2.60 | -- | 0.0712 | 41.73 | 10.69 | 2.69 | -26.17 | 6.85 | -14.75 | 4.56 |
| Suzhou Zelgen Biopharmaceuticals Co Ltd | 488.45m | -174.40m | 16.95bn | 867.00 | -- | 13.01 | -- | 34.71 | -0.6692 | -0.6692 | 1.86 | 4.92 | 0.1677 | 0.2615 | 4.39 | 563,380.80 | -6.54 | -27.13 | -11.06 | -39.20 | 92.64 | 92.75 | -39.00 | -220.71 | 1.83 | -- | 0.4159 | -- | 27.83 | 211.81 | 39.08 | -- | 41.38 | -- |
| Liaoning Cheng Da Co Ltd | 11.29bn | 346.30m | 17.24bn | 3.36k | 49.70 | 0.5835 | -- | 1.53 | 0.2268 | 0.2268 | 7.42 | 19.31 | 0.2371 | 5.28 | 5.77 | 3,365,262.00 | 0.2322 | 3.59 | 0.3297 | 5.21 | 13.90 | 14.15 | 0.9793 | 9.89 | 0.9129 | -- | 0.2831 | 15.93 | -25.97 | -10.97 | -80.95 | -21.26 | 7.04 | -- |
| Shandong Buchang Pharmaceuticals Co Ltd | 11.78bn | -293.31m | 18.11bn | 8.31k | -- | 1.62 | -- | 1.54 | -0.2619 | -0.2619 | 10.76 | 10.09 | 0.5777 | 1.08 | 9.78 | 1,416,955.00 | -2.26 | 3.26 | -3.13 | 4.72 | 58.25 | 74.71 | -3.92 | 4.85 | 0.5070 | 0.1602 | 0.2675 | 121.01 | -11.41 | -0.6219 | 120.85 | -29.93 | -16.56 | -36.72 |
| Joincare Pharmaceutical Group Ind. Co. | 15.89bn | 1.47bn | 20.93bn | 14.37k | 13.95 | 1.45 | -- | 1.32 | 0.8006 | 0.8006 | 8.65 | 7.73 | 0.4419 | 2.27 | 5.66 | 1,106,434.00 | 8.45 | 8.46 | 17.58 | 18.84 | 61.96 | 62.72 | 19.13 | 17.00 | 1.94 | -- | 0.2241 | 28.86 | -2.90 | 8.24 | -3.99 | 15.58 | 11.53 | 2.38 |
| Tianjin Pharmcetl Da Ren Tang Grp Cp Ltd | 8.04bn | 932.37m | 21.52bn | 4.62k | 26.60 | 3.85 | -- | 2.68 | 1.21 | 1.21 | 10.42 | 8.34 | 0.7567 | 2.64 | 3.24 | 1,740,681.00 | 8.66 | 8.96 | 13.55 | 12.80 | 45.80 | 40.82 | 11.44 | 10.67 | 1.31 | -- | 0.2047 | 56.93 | -0.3266 | 5.28 | 14.49 | 11.93 | -4.33 | 42.22 |
Data as of Nov 25 2024. Currency figures normalised to Shandong Buchang Pharmaceuticals Co Ltd's reporting currency: Chinese Yuan Renminbi CNY
2.68%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| China Southern Asset Management Co., Ltd.as of 30 Jun 2024 | 7.01m | 0.63% |
| Invesco Great Wall Fund Management Co. Ltd. (Invt Mgmt)as of 30 Jun 2024 | 4.76m | 0.43% |
| Yinhua Fund Management Co., Ltd.as of 30 Jun 2024 | 4.64m | 0.42% |
| GF Fund Management Co., Ltd.as of 30 Jun 2024 | 3.42m | 0.31% |
| China Universal Asset Management Co., Ltd.as of 30 Jun 2024 | 3.14m | 0.28% |
| The Vanguard Group, Inc.as of 31 Oct 2024 | 2.52m | 0.23% |
| China Asset Management Co., Ltd.as of 30 Jun 2024 | 1.19m | 0.11% |
| Harvest Fund Management Co., Ltd.as of 30 Jun 2024 | 1.13m | 0.10% |
| Penghua Fund Management Co., Ltd.as of 30 Jun 2024 | 982.63k | 0.09% |
| Western Leadbank Fund Management Co., Ltdas of 30 Jun 2024 | 919.99k | 0.08% |
More ▼
Data from 30 Jun 2024 - 30 Sep 2024Source: FactSet Research Systems Inc.
